Fibrin glue in renal and ureteral trauma. 1989

H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
Department of Surgery, King-Drew Medical Center, Los Angeles, California.

Fibrin glue (FG) made with highly concentrated human fibrinogen and clotting factors was used to achieve hemostasis of fourteen renal injuries and to seal three ureteral anastomoses in 15 patients. The cause of injury included twelve gunshot wounds, four stab wounds, and one iatrogenic ureteral injury. The mean intraoperative blood loss was 1.6 +/- 1.1 L (SD), and patients received 4 +/- 5 units of blood perioperatively. Utilizing the described techniques, FG was effective in achieving hemostasis and sealing ureteral suture lines against leakage in all cases. There were no cases of renal infection, rebleeding, urinary fistulas, delayed rupture, stone formation, or urinary tract obstruction. Two patients underwent re-exploration for causes unrelated to their renal or ureteral injuries. The use of FG was associated with less reliance on suture redundancy to achieve parenchymal hemostasis and perform ureteral anastomoses. FG sealing of renal and ureteral injuries is a safe and effective technique for controlling hemorrhage and sealing anastomoses. It is effective in the management of both superficial and deep renal injuries.

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005176 Factor XIII A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Coagulation Factor XIII,Factor XIII Transamidase,Fibrin Stabilizing Factor,Fibrinase,Laki-Lorand Factor,Blood Coagulation Factor XIII,Factor 13,Factor Thirteen,Laki Lorand Factor,Factor XIII, Coagulation,Stabilizing Factor, Fibrin,Transamidase, Factor XIII,XIII, Coagulation Factor
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen

Related Publications

H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
November 1994, The Journal of urology,
H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
August 1988, The Journal of trauma,
H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
September 1989, Journal of pediatric surgery,
H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
April 1990, The Journal of trauma,
H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
February 1996, Journal of endourology,
H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
May 1996, The Journal of urology,
H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
July 1990, The Journal of trauma,
H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
August 1985, The Annals of thoracic surgery,
H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
October 1992, Plastic and reconstructive surgery,
H B Kram, and H P Ocampo, and M P Yamaguchi, and R C Nathan, and W C Shoemaker
June 1994, BMJ (Clinical research ed.),
Copied contents to your clipboard!